00

Hubei Biocause Pharmaceutical Co LtdSHE 000627 Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Sep, 2024

Last price

Market cap $B

2.449

Small

Exchange

XSHE - Shenzhen Stock Exchange

000627.SZ Stock Analysis

00

Uncovered

Hubei Biocause Pharmaceutical Co Ltd is uncovered by Eyestock quantitative analysis.

Market cap $B

2.449

Dividend yield

3.48 %

Shares outstanding

4 940.63 B

Hubei Biocause Pharmaceutical Co., Ltd. is an investment holding company that engages in the insurance industry. The company is headquartered in Jingmen, Hubei and currently employs 2,239 full-time employees. is a China-based company principally engaged in insurance business, such as life insurance, health insurance and casualty insurance. The firm is also involved in pharmaceutical business and chemical business. The Company’s products include polypropylene and Ibuprofen. The firm distributes its products in domestic market and to overseas markets, with Central China and South China as its main markets.

View Section: Eyestock Rating